News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affinergy, Inc. Signs Exclusive Development & License Agreement With Synthes, Inc. (SYST)


9/11/2006 9:52:33 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Sept. 11, 2006--Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, announced that it has entered into a multi-year development & license agreement with Synthes. Affinergy will work exclusively with Synthes on multiple product applications across the Spine, Trauma and Craniomaxillofacial markets.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES